Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 30

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism

Rodriguez, Pedro, Laskowski, Lauren J., Pallais, Jean Pierre, Bock, Hailey A., Cavalco, Natalie G., Anderson, Emilie I., Calkins, Maggie M., Razzoli, Maria, Sham, Yuk Y., McCorvy, John D., Bartolomucci, Alessandro · 2024 · Journal of Biological Chemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jbc.2023.105549

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 81

  1. Ceddia, 2020, A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure, Clin. Sci., 134, 473, 10.1042/CS20190579 · DOI
  2. Weinstein, 2014, Role of Gsα in central regulation of energy and glucose metabolism, Horm. Metab. Res., 46, 841, 10.1055/s-0034-1387798 · DOI
  3. Smith, 2018, Biased signalling: from simple switches to allosteric microprocessors, Nat. Rev. Drug Discov., 17, 243, 10.1038/nrd.2017.229 · DOI · Paper page
  4. Preininger, 2004, G protein signaling: insights from new structures, Sci. STKE, 2004, re3, 10.1126/stke.2182004re3 · DOI
  5. Kobilka, 2007, G protein coupled receptor structure and activation, Biochim. Biophys. Acta Biomembr., 1768, 794, 10.1016/j.bbamem.2006.10.021 · DOI · Paper page
  6. Gurevich, 2020, Biased GPCR signaling: possible mechanisms and inherent limitations, Pharmacol. Ther., 211, 107540, 10.1016/j.pharmthera.2020.107540 · DOI
  7. Violin, 2014, Biased ligands at G-protein-coupled receptors: promise and progress, Trends Pharmacol. Sci., 35, 308, 10.1016/j.tips.2014.04.007 · DOI · Paper page
  8. Wisler, 2018, Biased G protein–coupled receptor signaling, Circulation, 137, 2315, 10.1161/CIRCULATIONAHA.117.028194 · DOI
  9. Manglik, 2016, Structure-based discovery of opioid analgesics with reduced side effects, Nature, 537, 185, 10.1038/nature19112 · DOI · Paper page
  10. Luttrell, 2018, Translating in vitro ligand bias into in vivo efficacy, Cell Signal., 41, 46, 10.1016/j.cellsig.2017.05.002 · DOI
  11. Markham, 2020, Oliceridine: first approval, Drugs, 80, 1739, 10.1007/s40265-020-01414-9 · DOI
  12. Tan, 2018, Biased ligands of G protein-coupled receptors (GPCRs): structure-functional selectivity relationships (SFSRs) and therapeutic potential, J. Med. Chem., 61, 9841, 10.1021/acs.jmedchem.8b00435 · DOI
  13. Klos, 2013, International union of basic and clinical pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors, Pharmacol. Rev., 65, 500, 10.1124/pr.111.005223 · DOI · Paper page
  14. Quell, 2017, Monitoring C3aR expression using a floxed tdTomato-C3aR reporter knock-in mouse, J. Immunol., 199, 688, 10.4049/jimmunol.1700318 · DOI · Paper page
  15. Sahu, 2021, The molecular identity of the TLQP-21 peptide receptor, Cell Mol. Life Sci., 78, 7133, 10.1007/s00018-021-03944-1 · DOI · Paper page
  16. Yanamadala, 2010, Complement in neuroprotection and neurodegeneration, Trends Mol. Med., 16, 69, 10.1016/j.molmed.2009.12.001 · DOI
  17. Norgauer, 1993, Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein, Eur. J. Biochem., 217, 289, 10.1111/j.1432-1033.1993.tb18245.x · DOI
  18. Molteni, 2017, Pharmacological and biochemical characterization of TLQP-21 activation of a binding site on CHO cells, Front. Pharmacol., 8, 167, 10.3389/fphar.2017.00167 · DOI
  19. Stephens, 2012, A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function, Cell Metab., 16, 33, 10.1016/j.cmet.2012.05.011 · doi:10.1016/j.cmet.2012.05.011
  20. Schraufstatter, 2002, Complement c3a and c5a induce different signal transduction cascades in endothelial cells, J. Immunol., 169, 2102, 10.4049/jimmunol.169.4.2102 · DOI · Paper page
  21. Gupta, 2012, Phosphorylation of C3a receptor at multiple sites mediates desensitization, β-arrestin-2 recruitment and inhibition of NF-κB activity in mast cells, PLoS One, 7, e46369, 10.1371/journal.pone.0046369 · doi:10.1371/journal.pone.0046369
  22. Vibhuti, 2011, Distinct and shared roles of β-arrestin-1 and β-arrestin-2 on the regulation of C3a receptor signaling in human mast cells, PLoS One, 6, e19585, 10.1371/journal.pone.0019585 · doi:10.1371/journal.pone.0019585
  23. Guo, 2011, Regulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinases, PLoS One, 6, 10.1371/journal.pone.0022559 · DOI
  24. Hsu, 2020, C3a elicits unique migratory responses in immature low-density neutrophils, Oncogene, 39, 2612, 10.1038/s41388-020-1169-8 · doi:10.1038/s41388-020-1169-8
  25. Hu, 2019, Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways, Eur. J. Pharmacol., 850, 135, 10.1016/j.ejphar.2019.02.020 · DOI
  26. Fairbanks, 2014, The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity, Pain, 155, 1229, 10.1016/j.pain.2014.03.012 · DOI
  27. Cero, 2017, The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis, Mol. Metab., 6, 148, 10.1016/j.molmet.2016.10.005 · DOI · Paper page
  28. Possenti, 2012, Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21, Biochem. J., 441, 511, 10.1042/BJ20111165 · doi:10.1042/bj20111165
  29. Sahu, 2019, Peptide/receptor Co-evolution explains the lipolytic function of the neuropeptide TLQP-21, Cell Rep., 28, 2567, 10.1016/j.celrep.2019.07.101 · DOI · Paper page
  30. Alexander, 2021, The concise guide to pharmacology 2021/22: G protein-coupled receptors, Br. J. Pharmacol., 178, S27
  31. Pasupuleti, 2007, Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans, J. Biol. Chem., 282, 2520, 10.1074/jbc.M607848200 · DOI
  32. Sonesson, 2007, Antifungal activity of C3a and C3a-derived peptides against Candida, Biochim. Biophys. Acta, 1768, 346, 10.1016/j.bbamem.2006.10.017 · DOI
  33. Coulthard, 2015, Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth, J. Immunol., 194, 3542, 10.4049/jimmunol.1403068 · DOI · Paper page
  34. Kanmura, 2010, The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma, J. Gastroenterol., 45, 459, 10.1007/s00535-009-0160-5 · DOI
  35. Bartolomucci, 2011, The extended granin family: structure, function, and biomedical implications, Endocr. Rev., 32, 755, 10.1210/er.2010-0027 · DOI · Paper page
  36. Bartolomucci, 2006, TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity, Proc. Natl. Acad. Sci. U. S. A., 103, 14584, 10.1073/pnas.0606102103 · DOI · Paper page
  37. Jethwa, 2007, VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters, Endocrinology, 148, 4044, 10.1210/en.2007-0038 · doi:10.1210/en.2007-0038
  38. Fargali, 2014, The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure, FASEB J., 28, 2120, 10.1096/fj.13-239509 · doi:10.1096/fj.13-239509
  39. Doolen, 2017, Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling, Glia, 65, 1976, 10.1002/glia.23208 · DOI · Paper page
  40. Li, 2021, The “C3aR antagonist” SB290157 is a partial C5aR2 agonist, Front. Pharmacol., 11, 2241, 10.3389/fphar.2020.591398 · DOI
  41. Mathieu, 2005, The C3a receptor antagonist SB 290157 has agonist activity, Immunol. Lett., 100, 139, 10.1016/j.imlet.2005.03.003 · DOI
  42. Olsen, 2020, TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome, Nat. Chem. Biol., 16, 841, 10.1038/s41589-020-0535-8 · DOI · Paper page
  43. Proctor, 2009, Complement factors C3a and C5a have distinct hemodynamic effects in the rat, Int. Immunopharmacol., 9, 800, 10.1016/j.intimp.2009.03.002 · doi:10.1016/j.intimp.2009.03.002
  44. Kroeze, 2015, PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome, Nat. Struct. Mol. Biol., 22, 362, 10.1038/nsmb.3014 · DOI · Paper page
  45. Cero, 2014, The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism, Structure, 22, 1744, 10.1016/j.str.2014.10.001 · doi:10.1016/j.str.2014.10.001
  46. Kenakin, 2015, The effective application of biased signaling to new drug discovery, Mol. Pharmacol., 88, 1055, 10.1124/mol.115.099770 · DOI
  47. Kenakin, 2012, A simple method for quantifying functional selectivity and agonist bias, ACS Chem. Neurosci., 3, 193, 10.1021/cn200111m · DOI · Paper page
  48. Rivolta, 2017, JMV5656, A novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells, Front. Cell. Neurosci., 11, 41, 10.3389/fncel.2017.00041 · DOI
  49. Beautrait, 2017, A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling, Nat. Commun., 8, 15054, 10.1038/ncomms15054 · DOI · Paper page
  50. Paksoy, 2022, Effects of the clathrin inhibitor Pitstop-2 on synaptic vesicle recycling at a central synapse in vivo, Front. Synaptic Neurosci., 14, 1056308, 10.3389/fnsyn.2022.1056308 · DOI
  51. Rowley, 2020, Potent thiophene antagonists of human complement C3a receptor with anti-inflammatory activity, J. Med. Chem., 63, 529, 10.1021/acs.jmedchem.9b00927 · DOI
  52. Cho, 2020, TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β, Biochem. Biophys. Res. Commun., 524, 764, 10.1016/j.bbrc.2020.01.111 · DOI
  53. Blasi, 1990, Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus, J. Neuroimmunol., 27, 229, 10.1016/0165-5728(90)90073-V · DOI · Paper page
  54. Kirshenbaum, 2019, Description and characterization of a novel human mast cell line for scientific study, Int. J. Mol. Sci., 20, 5520, 10.3390/ijms20225520 · DOI
  55. Ames, 2001, Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models, J. Immunol., 166, 6341, 10.4049/jimmunol.166.10.6341 · DOI · Paper page
  56. Gorman, 2021, Development of potent and selective agonists for complement C5a receptor 1 with in vivo activity, J. Med. Chem., 64, 16598, 10.1021/acs.jmedchem.1c01174 · DOI
  57. Pandey, 2019, Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1, J. Biol. Chem., 294, 9416, 10.1074/jbc.RA119.007485 · DOI
  58. Yang, 2017, Biased signaling at neural melanocortin receptors in regulation of energy homeostasis, Biochim. Biophys. Acta Mol. Basis Dis., 1863, 2486, 10.1016/j.bbadis.2017.04.010 · DOI
  59. Ghamari-Langroudi, 2015, G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons, Nature, 520, 94, 10.1038/nature14051 · DOI · Paper page
  60. Lotta, 2019, Human gain-of-function MC4R variants show signaling bias and protect against obesity, Cell, 177, 597, 10.1016/j.cell.2019.03.044 · DOI · Paper page
  61. Li, 2023, TLQP-21 is a low potency partial C3aR activator on human primary macrophages, Front. Immunol., 14
  62. Hutamekalin, 2010, Effect of the C3a-receptor antagonist SB 290157 on anti-OVA polyclonal antibody-induced arthritis, J. Pharmacol. Sci., 112, 56, 10.1254/jphs.09180FP · DOI
  63. Grundmann, 2018, Lack of beta-arrestin signaling in the absence of active G proteins, Nat. Commun., 9, 341, 10.1038/s41467-017-02661-3 · DOI · Paper page
  64. Li, 2008, Cyclic AMP plays a critical role in C3a-receptor mediated regulation of dendritic cells in antigen uptake and T-cell stimulation, Blood, 112, 5084, 10.1182/blood-2008-05-156646 · DOI
  65. Reid, 2013, Downsizing a human inflammatory protein to a small molecule with equal potency and functionality, Nat. Commun., 4, 2802, 10.1038/ncomms3802 · doi:10.1038/ncomms3802
  66. Rizzi, 2008, The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain, Neurosci. Lett., 441, 129, 10.1016/j.neulet.2008.06.018 · DOI
  67. Sarma, 2011, The complement system, Cell Tissue Res., 343, 227, 10.1007/s00441-010-1034-0 · DOI · Paper page
  68. Koc, 2021, Changes in VGF and C3aR1 gene expression in human adipose tissue in obesity, Mol. Biol. Rep., 48, 251, 10.1007/s11033-020-06043-9 · DOI · Paper page
  69. Lisci, 2019, Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21, PLoS One, 14, e0221517, 10.1371/journal.pone.0221517 · DOI
  70. Mamane, 2009, The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation, Diabetes, 58, 2006, 10.2337/db09-0323 · DOI · Paper page
  71. Lewis, 2017, Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gain, PLoS One, 12
  72. Regal, 2000, Minor role of the C3a receptor in systemic anaphylaxis in the Guinea pig, Immunopharmacology, 46, 15, 10.1016/S0162-3109(99)00152-6 · doi:10.1016/s0162-3109(99)00152-6
  73. Song, 2016, Small molecule-induced complement factor D (adipsin) promotes lipid accumulation and adipocyte differentiation, PLoS One, 11
  74. Lim, 2013, C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling, FASEB J., 27, 822, 10.1096/fj.12-220582 · DOI · Paper page
  75. Kashem, 2011, G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2, Eur. J. Pharmacol., 668, 299, 10.1016/j.ejphar.2011.06.027 · DOI
  76. Wang, 2023, Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins, Nat. Chem. Biol., 19, 1351, 10.1038/s41589-023-01339-w · DOI
  77. Yadav, 2023, Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors, Cell, 186, 4956, 10.1016/j.cell.2023.09.020 · DOI
  78. Settmacher, 2003, Structure-function studies of the C3a-receptor: C-terminal serine and threonine residues which influence receptor internalization and signaling, Eur. J. Immunol., 33, 920, 10.1002/eji.200323293 · DOI
  79. Lewis, 2023, A non-hallucinogenic LSD analog with therapeutic potential for mood disorders, Cell Rep., 42, 10.1016/j.celrep.2023.112203 · DOI
  80. Chan, 2014, Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype, J. Allergy Clin. Immunol., 134, 178, 10.1016/j.jaci.2013.12.1090 · DOI
  81. Woolhiser, 2001, IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma, Eur. J. Immunol., 31, 3298, 10.1002/1521-4141(200111)31:11<3298::AID-IMMU3298>3.0.CO;2-U · DOI

Cited by

See all 30

Metadata

Authors
Rodriguez, P., Laskowski, L. J., Pallais, J. P., Bock, H. A., Cavalco, N. G., Anderson, E. I., Calkins, M. M., Razzoli, M., Sham, Y. Y., McCorvy, J. D., & Bartolomucci, A.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2024-01
Volume
300
Issue
1
Pages
105549
ISSN
0021-9258
Cited by
30
References
7
Language
en
Licence
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK102496, R01DK117504)
  • National Institutes of Health
  • National Institute of General Medical Sciences (R35GM133421, T32DK083250)
  • National Institute of Allergy and Infectious Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism. https://app.cochat.ai/papers/10.1016/j.jbc.2023.105549
The paper
Rodriguez, P., Laskowski, L. J., Pallais, J. P., Bock, H. A., Cavalco, N. G., Anderson, E. I., Calkins, M. M., Razzoli, M., Sham, Y. Y., McCorvy, J. D., & Bartolomucci, A. (2024). Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105549

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.